DK453778A - Fremgangsmaade til fremstilling af xantinderivater - Google Patents

Fremgangsmaade til fremstilling af xantinderivater

Info

Publication number
DK453778A
DK453778A DK453778A DK453778A DK453778A DK 453778 A DK453778 A DK 453778A DK 453778 A DK453778 A DK 453778A DK 453778 A DK453778 A DK 453778A DK 453778 A DK453778 A DK 453778A
Authority
DK
Denmark
Prior art keywords
procedure
preparation
xantine
derivatives
xantine derivatives
Prior art date
Application number
DK453778A
Other languages
English (en)
Other versions
DK148260C (da
DK148260B (da
Inventor
S H A M Bergstrand
P G Kjellin
G A Persson
L M Soernby
Original Assignee
Draco Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ag filed Critical Draco Ag
Publication of DK453778A publication Critical patent/DK453778A/da
Publication of DK148260B publication Critical patent/DK148260B/da
Application granted granted Critical
Publication of DK148260C publication Critical patent/DK148260C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK453778A 1977-10-14 1978-10-12 Analogifremgangsmaade til fremstilling af 1,3,8-trisubstituerede xantinderivater eller salte deraf DK148260C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE7711581 1977-10-14
SE7711581A SE416810C (sv) 1977-10-14 1977-10-14 Forfarande for framstellning av xantinderivat med antiallergisk aktivitet

Publications (3)

Publication Number Publication Date
DK453778A true DK453778A (da) 1979-04-15
DK148260B DK148260B (da) 1985-05-20
DK148260C DK148260C (da) 1986-02-10

Family

ID=20332576

Family Applications (1)

Application Number Title Priority Date Filing Date
DK453778A DK148260C (da) 1977-10-14 1978-10-12 Analogifremgangsmaade til fremstilling af 1,3,8-trisubstituerede xantinderivater eller salte deraf

Country Status (21)

Country Link
US (1) US4233303A (da)
EP (1) EP0001735B1 (da)
JP (1) JPS5479296A (da)
AT (1) AT363491B (da)
AU (1) AU521585B2 (da)
CA (1) CA1109470A (da)
CS (1) CS208756B2 (da)
DD (1) DD139855A5 (da)
DE (1) DE2862017D1 (da)
DK (1) DK148260C (da)
FI (1) FI66383C (da)
HK (1) HK6385A (da)
HU (1) HU180219B (da)
IE (1) IE47884B1 (da)
IT (1) IT1109208B (da)
NO (1) NO147562C (da)
NZ (1) NZ188566A (da)
SE (1) SE416810C (da)
SG (1) SG85584G (da)
SU (1) SU755199A3 (da)
ZA (1) ZA785335B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
SE8002910L (sv) * 1980-04-18 1981-10-19 Draco Ab 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar
US4755517A (en) * 1986-07-31 1988-07-05 Warner-Lambert Company Derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US5298508A (en) * 1988-07-19 1994-03-29 The United States Of America As Represented By The Department Of Health And Human Services Irreversible inhibitors of adenosine receptors
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
US5321029A (en) * 1988-11-14 1994-06-14 Beecham-Wuelfing Gmbh & Co.K.G. Xanthines
IT1229195B (it) * 1989-03-10 1991-07-25 Poli Ind Chimica Spa Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
GB8929208D0 (en) * 1989-12-27 1990-02-28 Almirall Lab New xanthine derivatives
US5047534A (en) * 1990-03-26 1991-09-10 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
US5342841A (en) * 1992-03-12 1994-08-30 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
US5366977A (en) * 1992-09-29 1994-11-22 The United States Of America, As Represented By The Department Of Health And Human Services Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners
US5395836A (en) * 1993-04-07 1995-03-07 Kyowa Hakko Kogyo Co., Ltd. 8-tricycloalkyl xanthine derivatives
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5661153A (en) * 1994-07-19 1997-08-26 Japan Energy Corporation 1-arylpyrimidine derivatives and pharmaceutical use thereof
ATE247116T1 (de) * 1994-12-13 2003-08-15 Euro Celtique Sa Arylthioxanthine
CA2206804C (en) * 1994-12-13 2002-03-19 Euro-Celtique, S.A. Trisubstituted thioxanthines
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
US7579331B2 (en) 2003-04-25 2009-08-25 Novacardia, Inc. Method of improved diuresis in individuals with impaired renal function
BRPI0509753A (pt) * 2004-04-16 2007-10-16 Novacardia Inc composição farmacêutica e método de tratamento de doença cardiovascular
US20070049757A1 (en) * 2005-08-26 2007-03-01 Rieger Jayson M Methods for the synthesis of substituted amino uracils

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen
US3900474A (en) * 1973-05-14 1975-08-19 Kendall & Co Trifluoroalkyl, fluorobenzyl, pentafluorobenzyl, fluorobenzenesulfonyl, and pentafluorobenzenesulfonyl theophyllines
US4061753A (en) * 1976-02-06 1977-12-06 Interx Research Corporation Treating psoriasis with transient pro-drug forms of xanthine derivatives
CA1077932A (en) 1976-03-31 1980-05-20 Berlex Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases
US4120947A (en) * 1976-03-31 1978-10-17 Cooper Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases

Also Published As

Publication number Publication date
DE2862017D1 (en) 1982-10-28
US4233303A (en) 1980-11-11
SE416810C (sv) 1982-07-19
NZ188566A (en) 1984-07-06
SE7711581L (sv) 1979-04-15
SG85584G (en) 1985-06-07
IE47884B1 (en) 1984-07-11
CA1109470A (en) 1981-09-22
IE782041L (en) 1979-04-14
EP0001735B1 (en) 1982-09-01
HK6385A (en) 1985-02-01
NO147562C (no) 1983-05-18
ZA785335B (en) 1979-09-26
IT1109208B (it) 1985-12-16
SE416810B (sv) 1981-02-09
FI783126A (fi) 1979-04-15
IT7851499A0 (it) 1978-10-13
DK148260C (da) 1986-02-10
JPS5479296A (en) 1979-06-25
DD139855A5 (de) 1980-01-23
NO783471L (no) 1979-04-18
HU180219B (en) 1983-02-28
SU755199A3 (en) 1980-08-07
DK148260B (da) 1985-05-20
AT363491B (de) 1981-08-10
FI66383C (fi) 1984-10-10
CS208756B2 (en) 1981-09-15
FI66383B (fi) 1984-06-29
AU521585B2 (en) 1982-04-22
NO147562B (no) 1983-01-24
AU4036578A (en) 1980-04-17
EP0001735A1 (en) 1979-05-02
ATA714478A (de) 1980-09-15

Similar Documents

Publication Publication Date Title
DK63178A (da) Fremgangsmaade til fremstilling af pyrrodinderivater
DK536178A (da) Fremgangsmaade til fremstilling af stilbenderivater
DK581278A (da) Fremgangsmaade til fremstilling af aminderivater
DK148280C (da) Analogifremgangsmaade til fremstilling af thienothiazinderivater
DK155367C (da) Analogifremgangsmaade til fremstilling af 2-nitroimidazolderivater
DK453778A (da) Fremgangsmaade til fremstilling af xantinderivater
DK110778A (da) Fremgangsmaade til fremstilling af 4-acylamino-phenyl-ethanolaminer
DK153482C (da) Analogifremgangsmaade til fremstilling af 5-cyano-prostacyklinderivater
DK152732C (da) Fremgangsmaade til fremstilling af imidazodiazepinderivater
DK154137C (da) Analogifremgangsmaade til fremstilling af meta-sulfonamido-benzamidderivater
DK30578A (da) Fremgangsmaade til fremstilling af aminoalkoxyphenylderivater
DK312878A (da) Fremgangsmaade til fremstilling af indolderivater
DK237978A (da) Fremgangsmaade til fremstilling af alfafluormethyl-alfa-aminoalkansyrer
DK50778A (da) Fremgangsmaade til fremstilling af oxadiazolopyrimidinderivater
DK50878A (da) Fremgangsmaade til fremstilling af oxadiazolopyrimidinderivater
DK300978A (da) Fremgangsmaade til fremstilling af indolderivater
DK323978A (da) Fremgangsmaade til fremstilling af thiophenerivater
DK246878A (da) Fremgangsmaade til fremstilling af acylderivater
DK248978A (da) Fremgangsmaade til fremstilling af hydroxy-alfa-aminobenzylpenicillin
DK61778A (da) Fremgangsmaade til fremstilling af everninominderivater
DK214678A (da) Fremgangsmaade til fremstilling af benzazepinderivater
DK441878A (da) Fremgangsmaade til fremstilling af bibenzylderivater
DK417778A (da) Fremgangsmaade til fremstilling af thienobenzazepinderivater
DK147072C (da) Analogifremgangsmaade til fremstilling af ergolenderivater
DK158976C (da) Fremgangsmaade til fremstilling af alfa-cyanobenzyl

Legal Events

Date Code Title Description
PBP Patent lapsed